We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
It started with a trike – and ended up with a Harley-Davidson
The Danish company’s drugs for obesity could have a profound impact on healthcare, society and our relationship with food
Debates about crucial topics such as AI and net zero currently exclude large swaths of the population
Commonsense managerial concern for overburdened staff is the best remedy
You don’t have to believe in the afterlife to feel the beneficial effects of a religious service, at Christmas or otherwise
US biotech company’s stock worth nearly $500 at its peak in August 2021, currently trades at less than $87
What to wear for a seasonal stroll, hike – or run
Research into ‘colonisation resistance’ boosts efforts to harness microbes to improve general health
Belfast-based CV6 Therapeutics announced MHRA approval for trials of novel therapy pill
Researchers estimate prevalence of habit remained almost unchanged after early 2020
Company would have been better off following Roche’s route to market for anti-obesity treatment
Decision sets up another potentially landmark ruling on reproductive rights as the country prepares for 2024 election
Proposals include measures to encourage stockpiling and investment incentives for new factories in bloc
Anglo-Swedish pharma group agrees to buy Seattle-based biotech Icosavax
Organoid helps system recognise speech and solve maths problems showing potential of neuromorphic technology
We have grown fond of pathologising normal behaviour
Food agency says animal protein needed to address hunger and nutrient deficiencies in developing nations
Health Foundation warns of further reduction in real-terms spending because of high price growth
New approach is driving a wave of mergers and acquisitions in the healthcare industry
A four-day stay dedicated to your skin at a smart wellness destination in the capital’s greenbelt
Pharma group behind blockbuster drug wants to supersize its market impact
The Swiss pharma group needs to settle investor jitters with its latest acquisition
Adjustments for symptoms could benefit the wider workforce if fewer older women quit jobs
Steady shift towards outsourcing hip, knee and eye treatment expected to expand to other procedures despite concerns
Some high-achieving female workers still drink to prove themselves, but those going sober have found benefits
International Edition
